share_log

Titan Medical Inc. (NASDAQ:TMDI) Short Interest Up 2,748.9% in February

Titan Medical Inc. (NASDAQ:TMDI) Short Interest Up 2,748.9% in February

泰坦醫療股份有限公司 (TMDI) 2 月份短期利率上升 2,748.9%
Financial News Live ·  2023/03/11 01:22

Titan Medical Inc. (NASDAQ:TMDI – Get Rating) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 1,490,000 shares, a growth of 2,748.9% from the February 13th total of 52,300 shares. Based on an average trading volume of 3,610,000 shares, the days-to-cover ratio is presently 0.4 days.

泰坦醫療股份有限公司 (NASDAQ: TMDI — 獲取評級) 在二月份短期興趣大增長的接收者.截至 2 月 28 日,短期利息總共達 1,49 萬股,較 2 月 13 日的 52,300 股股份增長 2,748.9%。以 3,610,000 股的平均交易量計算,日數佔覆蓋率目前為 0.4 天。

Institutional Inflows and Outflows

機構流入和流出

A number of large investors have recently added to or reduced their stakes in the stock. SageView Advisory Group LLC acquired a new stake in shares of Titan Medical during the fourth quarter worth $66,000. JPMorgan Chase & Co. raised its holdings in shares of Titan Medical by 70.9% during the first quarter. JPMorgan Chase & Co. now owns 126,600 shares of the company's stock worth $67,000 after purchasing an additional 52,500 shares during the period. Kingsbury Capital Investment Advisors LLC raised its holdings in shares of Titan Medical by 394.6% during the third quarter. Kingsbury Capital Investment Advisors LLC now owns 224,288 shares of the company's stock worth $101,000 after purchasing an additional 178,939 shares during the period. AlphaQ Advisors LLC acquired a new stake in shares of Titan Medical during the fourth quarter worth $169,000. Finally, Essex LLC raised its holdings in shares of Titan Medical by 17.9% during the third quarter. Essex LLC now owns 2,364,218 shares of the company's stock worth $1,064,000 after purchasing an additional 359,581 shares during the period. 3.55% of the stock is currently owned by institutional investors.

一些大型投資者最近增加或減少了他們在股票中的股份。世景諮詢集團有限責任公司在第四季度收購了泰坦醫療股份的新股份,價值 66,000 美元。摩根大通公司於第一季增加其對泰山醫療股份的持股量達 70.9%。摩根大通公司在期內另外購買 52,500 股股票後,現在擁有該公司股票的 126,600 股價值 67,000 美元。金斯伯里資本投資顧問有限責任公司在第三季度上調了其持有的泰坦醫療股份 394.6%.金斯伯里資本投資顧問有限責任公司現在擁有該公司股票的 224,288 股價值 101,000 美元後,在此期間額外購買 178,939 股股票。阿爾法克顧問有限責任公司在第四季度收購了泰坦醫療股份的新股份,價值 169,000 美元。最後, 埃塞克斯有限責任公司提出了泰坦醫療的股份持有 17.9% 在第三季度.在此期間額外購買 359,581 股股票後,埃塞克斯有限責任公司現在擁有該公司股票的 2,364,218 股價值 1,064,000 美元。3.55% 的股票目前由機構投資者擁有。

Get
取得
Titan Medical
泰坦醫療
alerts:
警報:

Titan Medical Trading Down 26.3 %

泰坦醫療交易下跌 26.3%

NASDAQ TMDI traded down $0.05 during trading hours on Friday, reaching $0.14. 7,711,949 shares of the company traded hands, compared to its average volume of 9,319,135. Titan Medical has a 12 month low of $0.13 and a 12 month high of $1.20. The company has a 50 day moving average of $0.58 and a two-hundred day moving average of $0.54.

納斯達克 TMDI 於周五交易時間內下跌 0.05 美元,達 0.14 美元。該公司交易手的 7,711,949 股,相比其平均交易量為 9,319,135 股。泰坦醫療有一個 12 個月的低點 0.13 美元和 12 個月的新高點 1.20 美元。該公司有一個 50 日移動平均線 0.58 美元和 200 日移動平均線 0.54 美元。

Titan Medical Company Profile

泰坦醫療公司簡介

(Get Rating)

(取得評分)

Titan Medical, Inc engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.

泰坦醫療股份有限公司從事計算機輔助機器人手術技術的研究和開發,用於微創手術(MIS)中的應用。它的產品組合是 Eos 系統,是一種機器人單一進出手術,具有雙 3D 和 2D 定義視覺系統,多重關節儀器和一個外科醫生工作站。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on Titan Medical (TMDI)
  • 2 Offshore Drilling Stocks Set to Extract Big Profits
  • Three Staples Stocks With Double-Digit Upside Ahead
  • Can Investors Trust Consumers to Lift American Outdoor Brands?
  • How to Buy High Yielding Dividend Stocks
  • Oracle Has Spoken: Shares Fall 5%
  • 獲取有關泰坦醫療研究報告的免費副本
  • 2 海上鑽探股票將提取巨額利潤
  • 前面有兩位數字的三個主要股票
  • 投資者可以信任消費者提升美國戶外品牌嗎?
  • 如何購買高收益股息股票
  • 甲骨文已經說話:股價下跌 5%

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接收泰坦醫療日報的最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Titan Medical 和相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論